UFP Technologies, Inc.

UFPT Healthcare Medical Devices

UFP Technologies, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $602.8 million, up 19.5% from fiscal 2024. In the quarter to June 2026, revenue grew 15.1%, EPS grew 20.6%, free cash flow fell 35.8% and total debt fell 19.6%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.

291.67 5.52 −1.86%
Market cap
$2.3B
P/E
31.2×
Fwd P/E
23.6×
Dividend yield
—
F-score
5/9
Altman Z
6.86
Beneish M
−2.57
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
ROE

+8 more TTM periods

18.31% 17.82% 17.17% 17.05%
Piotroski F-Score
6 5 5 4
ROA
10.40% 10.64% 10.42% 10.98%
ROIC
10.65% 10.44% 10.15% 10.29%
Return on Tangible Assets
34.73% 33.28% 30.43% 30.96%
Average Days of Receivables
53.10 53.42 61.48 67.82
Free Cash Flow per Share
11.34 10.26 9.01 7.95
Free Cash Flow
87.47 79.03 69.55 61.50
Capital Expenditures
(12.02) (12.87) (11.75) (10.08)
Other line items
Cash ROIC
15.01% 13.31% 11.40% 10.20%
Accounts Receivable Turnover
6.70 6.78 6.10 6.19
Accounts Payable Turnover
15.35 17.81 15.01 16.24
Inventory Turnover
4.89 4.96 4.75 4.88
Average Days of Payables
25.14 20.50 23.79 26.64
Days of Inventory on Hand
73.56 73.32 78.64 80.89
Tax Rate
(0.18) (0.17) (0.18) (0.18)
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
12.56% 12.85% 13.10% 13.27%
Share Based Compensation of Revenue
1.42% 1.47% 1.54% 1.63%
Interest Coverage
8.27 9.42 10.60 12.40
Operating CF/Net income
1.48 1.35 1.18 0.99
Depreciation/Fixed assets
0.24 0.24 0.25 0.26
Capex/Depreciation
(0.64) (0.67) (0.60) (0.51)
Revenue per Share
77.54 78.23 78.86 81.61
Operating CF per Share
12.90 11.93 10.53 9.25
Capex per Share
(1.56) (1.67) (1.52) (1.30)
Capex to Sales
0.02 0.02 0.02 0.02

Fold the line items

Columns are period end dates